Proactive Investors - Run By Investors For Investors

e-Therapeutics plc focused on commercialisation and making alliances

e-Therapeutics plc (LON:ETX) is targeting partners to accelerate the development of its drug discovery engine, it told investors on Tuesday.

Malcolm Young, chief executive, tells Proactive that “making alliances with much larger companies is absolutely our foreground so that’s where we need to go, that’s where our frontier is, that’s where we need to make the advances.”

He adds “commercialisation as a focus in the company has really grown in significance in this last year,” and that the firm is looking for partnerships as a way to recognise the commercial value of both late stage and early stage products.

Meet Eco (Atlantic) Oil & Gas Ltd, Bushveld Minerals Limited, Ncondezi Energy and Hurricane Energy PLC at our event, London, 13 June 2016. Register here »
View full ETX profile

e-Therapeutics plc Timeline

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.